Dr. Sandhya Krishan

D.D.S. | Dentist



  
  2005 W Hebron Pkwy, Carrollton
  Texas, 70501

  972-395-0150    972-395-0150 Maps & Directions
Dr. Sandhya Krishan is a Carrollton, Texas based Dentist who is specialized in Dentist. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 2005 W Hebron Pkwy, Carrollton. Patients can reach her at 972-395-0150.
Dr. Sandhya Krishan is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Sandhya Krishan speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Sandhya Krishan
Specialization: Dentist
Gender:Female
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:2005 W Hebron Pkwy, Carrollton,
Texas, 70501
Phone:972-395-0150
Fax:972-395-0150
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 0648583872
Enrollment ID: I20150717000397
NPI Number: 1376700724
NPI Enumeration Date: 21 May, 2008
NPI Last Update On: 19 Jul, 2019

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2005 W Hebron Pkwy,
Carrollton, Texas
Zip: 75010-6522
Phone Number: 972-395-0150
Fax Number: 972-395-0107
Patients can reach Dr. Sandhya Krishan at 2005 W Hebron Pkwy, Carrollton, Texas or can call to book an appointment on 972-395-0150. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: